Free Trial
OTCMKTS:MYMX

Mymetics (MYMX) Stock Price, News & Analysis

$0.0003 0.00 (0.00%)
As of 04/28/2025

About Mymetics Stock (OTCMKTS:MYMX)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0003
$0.0010
Volume
N/A
Average Volume
0 shs
Market Capitalization
$45.60
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Receive MYMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter.

MYMX Stock News Headlines

Sp Bmv Ipc Esg Tilted Heavy (MYMX)
PLTXF PlantX Life Inc.
The 5 Stocks to Buy for Maximum Gains During Trump's Presidency
New Presidency. New Policy. New Profit Potential. Trump’s return brings fresh momentum to specific sectors. This free report outlines five stocks poised to outperform in a shifting political and economic landscape.
Mymetics Stock (OTC:MYMX), Short Interest Report
Mymetics Corporation (MYMX)
See More Headlines

MYMX Stock Analysis - Frequently Asked Questions

Mymetics' stock was trading at $0.0010 at the start of the year. Since then, MYMX stock has decreased by 70.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mymetics investors own include Dynavax Technologies (DVAX), Fujitsu (FJTSY), Genocea Biosciences (GNCA), Maxar Technologies (MAXR), Revance Therapeutics (RVNC), Axcelis Technologies (ACLS) and Allied Gaming & Entertainment (AGAE).

Company Calendar

Today
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MYMX
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.08 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
144,000
Optionable
Not Optionable
Beta
1.63
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:MYMX) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners